Search
for

    Sort by

    Research 241–270 of 788

    1. Innate type 2 immunity controls hair follicle commensalism by Demodex mites Immunity · 2022 · 24 citations
    2. SARS-CoV-2 Non-Structural Proteins and Their Roles in Host Immune Evasion Viruses · 2022 · 52 citations
    3. JAK inhibition decreases the autoimmune burden in Down syndrome eLife · 2024 · 18 citations
    4. JAK inhibition decreases the autoimmune burden in Down syndrome eLife · 2024 · 2 citations
    5. Mesenchymal Stem Cells Antagonize IFN-Induced Proinflammatory Changes and Growth Inhibition Effects via Wnt/β-Catenin and JAK/STAT Pathway in Human Outer Root Sheath Cells and Hair Follicles International journal of molecular sciences · 2021 · 14 citations
    6. Suspected upadacitinib-associated drug hypersensitivity mimicking disease exacerbation in ulcerative colitis Clinical Journal of Gastroenterology · 2026
    7. Genetic Variants and Protective Immunity against SARS-CoV-2 Genes · 2022 · 5 citations
    8. Mechanisms of Puerariae Lobatae Radix in regulating sebaceous gland secretion: insights from network pharmacology and experimental validation Frontiers in Pharmacology · 2024 · 3 citations
    9. LB1034 Meta-analysis of scalp transcriptome defines alopecia areata subtypes and molecular response to four (4) treatments with jak inhibiting properties Journal of Investigative Dermatology · 2024
    10. Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalis The Journal of Dermatology · 2024 · 7 citations
    11. Recalcitrant alopecia areata responsive to leflunomide and anthralin—Potentially undiscovered JAK/STAT inhibitors? Pediatric dermatology · 2018 · 11 citations
    12. Poster Abstracts Fundamental & Clinical Pharmacology · 2017
    13. Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies American Journal of Clinical Dermatology · 2026
    14. JAK-centric explainable few-shot gene-expression diagnosis framework for alopecia via MultiPLIER priors and relation-style set-to-set comparison Frontiers in Molecular Biosciences · 2026
    15. Dual improvement of alopecia areata and immune thrombocytopenia with baricitinib: a case report Skin Health and Disease · 2025
    16. Baricitinib Attenuates IFN-γ and Polyinosinic:polycytidylic Acid‒Induced Mitochondrial Damage and Inflammasome Activation in Human Keratinocytes Journal of Investigative Dermatology · 2022
    17. Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases Frontiers in immunology · 2019 · 88 citations
    18. Considerations for the Treatment Strategy of Relapse After Tofacitinib Therapy in Alopecia Areata Journal of Cosmetic Dermatology · 2025
    19. Revolutionary Approaches to Hair Regrowth: Follicle Neogenesis, Wnt/ß-Catenin Signaling, and Emerging Therapies Cells · 2025
    20. Comparative analysis of therapeutic outcomes in pediatric versus adult ophiasis-pattern alopecia areata: A review of treatment modalities and disease course Saudi Journal of Internal Medicine · 2026
    21. Baricitinib in the Management of Coexisting Alopecia Areata and Atopic Dermatitis: A Case Report NATIONS UNIVERSITY INTERNATIONAL JOURNAL OF MULTI-DISCIPLINARY STUDIES · 2025
    22. Psychological Stress-Induced Pathogenesis of Alopecia Areata: Autoimmune and Apoptotic Pathways International journal of molecular sciences · 2023 · 3 citations
    23. Real‐world experience and long‐term evaluation of tofacitinib in refractory alopecia areata: A prospective, open‐label, single‐center study in Asian Arab population Dermatologic Therapy · 2022 · 2 citations
    24. The use of topical ruxolitinib 1.5% cream in frontal fibrosing alopecia: A case report JAAD Case Reports · 2024 · 6 citations
    25. Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement Australasian Journal of Dermatology · 2025
    26. Personalized Medicine in the Field of Inflammatory Skin Disorders Journal of Personalized Medicine · 2022 · 2 citations
    27. Alopecia Areata of the Nails: Diagnosis and Management Journal of Clinical Medicine · 2024 · 2 citations
    28. Targeting the Janus Kinase Family in Autoimmune Skin Diseases Frontiers in Immunology · 2019 · 124 citations
    29. Review of Promising Off-Label Use of Deucravacitinib International Journal of Molecular Sciences · 2025
    30. Role of janus kinase inhibitors in the treatment of alopecia areata Drug design, development and therapy · 2018 · 53 citations